(Q36677570)

English

Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone

scientific article published on 28 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

James L. Gulley

3

object named as

James L Gulley

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

author name string

Shenhong L Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Elizabeth Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Philip M Arlen

4

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Clara C Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

William D Figg

6

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

William L Dahut

7

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

publication date

28 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

525-528

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Is there a favorable subset of patients with prostate cancer who develop oligometastases?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Prostate cancer clinical trial end points: "RECIST"ing a step backwards.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Osteoblasts in prostate cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Dynamic process of prostate cancer metastasis to bone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2006.06654.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2006.06654.X

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36677570&oldid=1645817857"